Gene: GAN
Official Full Name: gigaxoninprovided by HGNC
Gene Summary: This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02140 | GAN Knockout cell line (HeLa) | Human | GAN | 1:3~1:6 | Negative | Online Inquiry |
KO02141 | GAN Knockout cell line (HCT 116) | Human | GAN | 1:2~1:4 | Negative | Online Inquiry |
KO02142 | GAN Knockout cell line (HEK293) | Human | GAN | 1:3~1:6 | Negative | Online Inquiry |
KO02143 | GAN Knockout cell line (A549) | Human | GAN | 1:3~1:4 | Negative | Online Inquiry |
GAN Gene Knockout Cell Lines are innovative biological tools designed for the targeted disruption of the GAN (Gelsolin Actin-binding Protein) gene in mammalian cells. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines enable researchers to create precise modifications in the genomic structure, leading to a complete knockout of the GAN gene. This allows for in-depth studies of GAN's role in cellular processes, including cytoskeletal dynamics, cell migration, and immune responses.
The mechanism of action involves the introduction of specific guide RNAs (gRNAs) that direct the Cas9 nuclease to the target GAN gene locus, resulting in double-stranded breaks. The subsequent repair process typically leads to insertions or deletions (indels) that disrupt the gene function. The generation of these knockout cell lines is critical for elucidating the pathophysiological implications of GAN mutations, which are linked to various diseases, including neurodegenerative disorders and certain cancers.
The scientific importance of GAN Gene Knockout Cell Lines extends to both fundamental research and clinical applications. They are invaluable in the identification of therapeutic targets, screening potential drug candidates, and understanding mechanisms of disease progression. As more discoveries link gene mutations to specific health conditions, having these specialized cell lines accelerates the pathway from laboratory research to potential clinical therapies.
Compared to traditional knockout methods, GAN Gene Knockout Cell Lines offer significant advantages, including higher efficiency, reduced off-target effects, and easier implementation in various cell types. Additionally, the accompanying detailed documentation and support from our team ensure that researchers can seamlessly integrate these tools into their projects.
By providing this state-of-the-art product, we underscore our commitment to advancing biological research and enhancing scientific understanding. Our expertise in biotechnological development and thorough validation of these cell lines ensure their reliability and integrity, making GAN Gene Knockout Cell Lines a valuable asset for any laboratory focused on cellular and genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.